The Clinical Effects of Type 2 Diabetes Patient Management Using Digital Healthcare Technology: A Systematic Review
Ji-Eun Kim1, Tae-Shin Park1, Kwang Joon Kim1
1College of Pharmacy, Mokpo National University, Youngsan-ro 1666, Cheonggye-myeon, Mokpo 58554, Korea.
Healthcare (Basel, Switzerland)
|March 25, 2022
Summary
Digital healthcare technology significantly improves HbA1c and triglyceride levels for type 2 diabetes patients. This approach offers a promising tool for better diabetes management, though further research is recommended.
Area of Science:
- Endocrinology and Metabolic Diseases
- Digital Health
- Medical Informatics
Background:
- Type 2 diabetes management remains a challenge, with low disease control rates.
- Digital healthcare technology offers continuous patient monitoring and management solutions.
- The integration of technology in daily life presents new avenues for chronic disease care.
Purpose of the Study:
- To evaluate the clinical effectiveness of digital healthcare technology for type 2 diabetes management.
- To synthesize evidence from randomized controlled trials on digital health interventions for diabetes.
Main Methods:
- A meta-analysis was performed on randomized controlled trials (RCTs).
- Literature search conducted across PubMed, Embase, and Cochrane Library up to August 2021.
- Included 12 RCTs from an initial pool of 2354 articles.
Main Results:
- Digital healthcare technology significantly reduced HbA1c levels (SMD = -0.49, p < 0.00001).
- A marginal decrease in triglyceride levels was observed (SMD = -0.18, p = 0.06).
- No significant effects were found on BMI, total cholesterol, HDL-C, LDL-C, systolic BP, or diastolic BP.
Conclusions:
- Digital healthcare technology demonstrates potential in improving key glycemic and lipid markers for type 2 diabetes.
- The findings suggest a beneficial role for digital health tools in diabetes care.
- Further high-quality RCTs are warranted to confirm and expand upon these clinical effects.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
426
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
426
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes: Symptoms, Diagnosis, and Complications
844
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
844
Carbohydrate Metabolism
12.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.1K
Pathophysiology of Diabetes
1.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K


